[Federal Register Volume 83, Number 117 (Monday, June 18, 2018)]
[Notices]
[Pages 28226-28227]
[FR Doc No: 2018-12947]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 2326-053]

Notice of Application Accepted for Filing, Soliciting Comments,
Motions To Intervene, and Protests; Great Lakes Hydro America, LLC.

    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection:
    a. Type of Application: Request for a temporary variance from
elevation requirements.
    b. Project No.: 2326-053.
    c. Date Filed: May 23, 2018.
    d. Applicant: Great Lakes Hydro America, LLC.
    e. Name of Project: Cross Power Hydroelectric Project.
    f. Location: The project is located on the Androscoggin River in
Coos County, New Hampshire.
    g. Filed Pursuant to: Federal Power Act, 16 U.S.C. 791a-825r.
    h. Applicant Contact: Ms. Kelly Maloney, Great Lakes Hydro America,
LLC, 150 Main Street, Lewiston, ME 04240,<PHONE_NUMBER>.
    i. FERC Contact: Zeena Aljibury,<PHONE_NUMBER>,
[email protected].
    j. Deadline for filing comments, motions to intervene, and
protests: June 26, 2018.
    The Commission strongly encourages electronic filing. Please file
motions to intervene, protests, comments, or recommendations using the
Commission's eFiling system at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can submit brief comments up to 6,000
characters, without prior registration, using the eComment system at
http://www.ferc.gov/docs-filing/ecomment.asp. You must include your
name and contact information at the end of your comments. For
assistance, please contact FERC Online Support at
[email protected],<PHONE_NUMBER> (toll free), or (202) 502-
8659 (TTY). In lieu of electronic filing, please send a paper copy to:
Secretary, Federal Energy Regulatory Commission, 888 First Street NE,
Washington, DC 20426. The first page of any filing should include
docket number P-2326-053.
    k. Description of Request: Great Lakes Hydro America, LLC requests
Commission approval for temporary modifications from normal reservoir
elevation to perform spillway repairs at the Cross Power Project. The
licensee is proposing to lower the headpond to elevation 917.7 feet
United Sates Geologic Datum (USGS), six inches below the concrete crest
of the spillway (for worker safety), while the flashboards are being
installed and removed. Once the flashboard work is completed, the
licensee will maintain the headpond at or above the spillway crest
elevation of 918.2 feet. Great Lakes Hydro America, LLC is proposing to
begin the drawdown starting on July 1, 2018, and continue through
September 2018. Great Lakes Hydro America, LLC does not foresee any
recreational impacts for this project since the repair activities are
limited to a section of the Androscoggin River with limited access.
    l. Locations of the Application: A copy of the application is
available for inspection and reproduction at the Commission's Public
Reference Room, located at 888 First Street NE, Room 2A, Washington, DC
20426, or by calling<PHONE_NUMBER>. This filing may also be viewed on
the Commission's website at http://www.ferc.gov/docs-filing/elibrary.asp. Enter the docket number excluding the last three digits
in the docket number field to access the document. You may also
register online at http://www.ferc.gov/docs-filing/esubscription.asp to
be notified via email of new filings and issuances related to this or
other pending projects. For assistance, call 1-866-208- 3676 or email
[email protected], for TTY, call<PHONE_NUMBER>. A copy is
also available for inspection and reproduction at the address in item
(h) above.
    m. Individuals desiring to be included on the Commission's mailing
list should so indicate by writing to the Secretary of the Commission.
    n. Comments, Protests, or Motions to Intervene: Anyone may submit
comments, a protest, or a motion to intervene in accordance with the
requirements of Rules of Practice and Procedure, 18 CFR 385.210, .211,
.214. In determining the appropriate action to take, the Commission
will consider all protests or other comments filed, but only those who
file a motion to intervene in accordance with the Commission's Rules
may become a party to the proceeding. Any comments, protests, or
motions to intervene must be received on or before the specified
comment date for the particular application.
    o. Filing and Service of Responsive Documents: Any filing must (1)
bear in all capital letters the title COMMENTS, PROTEST, or MOTION TO
INTERVENE as applicable; (2) set forth in the heading the name of the
applicant and the project number of the application to which the filing
responds; (3) furnish the name, address, and telephone number of the
person protesting or

intervening; and (4) otherwise comply with the requirements of 18 CFR
385.2001 through 385.2005. All comments, motions to intervene, or
protests must set forth their evidentiary basis and otherwise comply
with the requirements of 18 CFR 4.34(b). All comments, motions to
intervene, or protests should relate to project works which are the
subject of the license surrender. Agencies may obtain copies of the
application directly from the applicant. A copy of any protest or
motion to intervene must be served upon each representative of the
applicant specified in the particular application. If an intervener
files comments or documents with the Commission relating to the merits
of an issue that may affect the responsibilities of a particular
resource agency, they must also serve a copy of the document on that
resource agency. A copy of all other filings in reference to this
application must be accompanied by proof of service on all persons
listed in the service list prepared by the Commission in this
proceeding, in accordance with 18 CFR 4.34(b) and 385.2010.

    Dated: June 12, 2018.
Kimberly D. Bose,
Secretary.
[FR Doc. 2018-12947 Filed 6-15-18; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 183 (Monday, September 22, 2014)]
[Notices]
[Pages 56588-56589]
[FR Doc No: 2014-22450]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2007-D-0369]

Bioequivalence Recommendations for Estradiol Vaginal Cream; Draft
Guidance for Industry; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a revised draft guidance for industry entitled ``Draft
Guidance on Estradiol.'' The guidance provides specific recommendations
on the design of bioequivalence (BE) studies to support abbreviated new
drug applications (ANDAs) for estradiol vaginal cream. This draft
guidance is a revised version of a previously issued draft guidance of
the same subject.

DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency considers your comments on
this draft guidance before it begins work on the final version of the
guidance, submit either electronic or written comments on the draft
guidance by November 21, 2014.

ADDRESSES: Submit written requests for single copies of the draft
guidance to the Division of Drug Information, Center for Drug
Evaluation and Research, Food and Drug Administration, 10001 New
Hampshire Ave., Hillandale Building, 4th Floor, Silver Spring, MD
20993. Send one self-addressed adhesive label to assist that office in
processing your requests. See the SUPPLEMENTARY INFORMATION section for
electronic access to the draft guidance document.
    Submit electronic comments on the draft guidance to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Kris Andr[eacute], Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 75, Rm. 1615, Silver Spring, MD 20993, 240-402-
7800.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of June 11, 2010 (75 FR 33311), FDA
announced the availability of a guidance for industry entitled
``Bioequivalence Recommendations for Specific Products,'' which
explained the process that would be used to make product-specific BE
recommendations available to the public on FDA's Web site at http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm. As described in that guidance, FDA adopted this process as
a means to develop and disseminate product-specific BE recommendations
and to provide a meaningful opportunity for the public to consider and
comment on those recommendations. This notice announces the
availability of revised draft BE recommendations for estradiol vaginal
cream.
    ANDA 086069 for Estrace Cream (estradiol vaginal cream, USP, 0.01%)
was initially approved by FDA in January 1984. In August 2009, FDA
issued a draft guidance for industry on BE recommendations for generic
estradiol vaginal cream. FDA is now issuing a revised version of the
draft BE recommendations for estradiol vaginal cream. This revised
draft guidance changes the recommendation for an in

vivo pharmacokinetic BE study from a parallel study design to a
crossover study design, but is the same in all other respects.
    In January 2005, Warner Chilcott, Inc., submitted a citizen
petition requesting that FDA stay final approval and/or the effective
date of final approval of any ANDA that relies on Estrace Cream as the
reference listed drug unless the ANDA meets certain requirements
related to demonstrating bioequivalence. FDA reviewed the issues raised
in the petition and is responding to the petition (see FDA letter to
Warner Chilcott, Inc, Docket No. FDA-2005-P-0006, available at http://www.regulations.gov).
    This draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the Agency's current thinking on the design
of BE studies to support ANDAs for estradiol vaginal cream. It does not
create or confer any rights for or on any person and does not operate
to bind FDA or the public. An alternative approach may be used if such
approach satisfies the requirements of the applicable statutes and
regulations.

II. Comments

    Interested persons may submit either electronic comments regarding
this document to http://www.regulations.gov or written comments to the
Division of Dockets Management (see ADDRESSES). It is only necessary to
send one set of comments. Identify comments with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.

III. Electronic Access

    Persons with access to the Internet may obtain the document at
either http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm or http://www.regulations.gov.

    Dated: September 16, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-22450 Filed 9-19-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 85, Number 250 (Wednesday, December 30, 2020)]
[Notices]
[Pages 86570-86571]
[FR Doc No: 2020-28816]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-D-1804]

Product Labeling for Laparoscopic Power Morcellators; Guidance
for Industry and Food and Drug Administration Staff; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of a final guidance entitled ``Product Labeling for
Laparoscopic Power Morcellators.'' This guidance updates recommended
``Contraindications'' and ``Warnings'' information to be included in
product labeling to reflect the state of the science and available
technology regarding use of laparoscopic power morcellators (LPMs).
These labeling recommendations are intended to enhance, but not
replace, the physician-patient discussion of the benefits and risks of
use of LPMs that uniquely pertain to individual patients.

DATES: The announcement of the guidance is published in the Federal
Register on December 30, 2020.

ADDRESSES: You may submit either electronic or written comments on
Agency guidances at any time as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2014-D-1804 for ``Product Labeling for Laparoscopic Power
Morcellators.'' Received comments will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday,<PHONE_NUMBER>.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852,<PHONE_NUMBER>.
    You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
    An electronic copy of the guidance document is available for
download from the internet. See the SUPPLEMENTARY INFORMATION section
for information on electronic access to the guidance. Submit written
requests for a single hard copy of the guidance document entitled
``Product Labeling for Laparoscopic Power Morcellators'' to the Office
of Policy, Guidance and Policy Development, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5431, Silver Spring, MD 20993-0002. Send one self-
addressed adhesive label to assist that office in processing your
request.

FOR FURTHER INFORMATION CONTACT: Veronica Price, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 2659, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    Following issuance of the 2014 guidance document entitled
``Immediately in Effect Guidance Document: Product Labeling for
Laparoscopic Power Morcellators,'' FDA has continued to consider new
scientific information and the input of stakeholders. Additional
scientific information is available that stratifies the risks of an
undetected uterine cancer in women with presumed fibroids based on age.
    FDA also considered scientific information pertaining to the risk
of spreading benign uterine tissue beyond the uterus during gynecologic
surgeries

when LPMs are used. Parasitic myomas and disseminated peritoneal
leiomyomatosis, while benign, have been associated with the need for
additional surgery due to symptoms such as abdominal pain and
distension. Finally, FDA considered additional available mitigations
for the spread of uterine tissue. Since 2014, FDA has provided
marketing authorization for LPM containment systems intended to isolate
and contain tissue that is considered benign. These products have been
shown, through bench testing and simulated use testing, to contain such
tissue during morcellation.
    For these reasons, FDA is updating its recommendations, as
originally described in the 2014 guidance document, concerning the
content and format of certain labeling information for LPMs.
Specifically, FDA is recommending that manufacturers incorporate into
the labeling for these devices information providing greater
specificity regarding the risks of use as it relates to age,
information regarding the risk of spreading benign uterine tissue, and
information regarding the use of LPM containment systems.
    A notice of availability of the draft guidance appeared in the
Federal Register of February 26, 2020 (85 FR 11093). FDA considered
comments received and revised the guidance as appropriate in response
to the comments, including revisions to further discuss shared decision
making that should occur between a physician and patient prior to
undergoing the procedure, to elaborate on the benefits and risks of LPM
containment systems, and to refine one of the sample warning
statements.
    This guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). The guidance represents the
current thinking of FDA on product labeling for laparoscopic power
morcellators. It does not establish any rights for any person and is
not binding on FDA or the public. You can use an alternative approach
if it satisfies the requirements of the applicable statutes and
regulations.

II. Electronic Access

    Persons interested in obtaining a copy of the guidance may do so by
downloading an electronic copy from the internet. A search capability
for all Center for Devices and Radiological Health guidance documents
is available at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/guidance-documents-medical-devices-and-radiation-emitting-products. This guidance document is also
available at https://www.regulations.gov and at https://www.fda.gov/regulatory-information/search-fda-guidance-documents. Persons unable to
download an electronic copy of ``Product Labeling for Laparoscopic
Power Morcellators'' may send an email request to<EMAIL_ADDRESS>to receive an electronic copy of the document.
Please use the document number 1400052 and complete title to identify
the guidance you are requesting.

III. Paperwork Reduction Act of 1995

    While this guidance contains no collection of information, it does
refer to previously approved FDA collections of information. Therefore,
clearance by the Office of Management and Budget (OMB) under the
Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3521) is not
required for this guidance. The previously approved collections of
information are subject to review by OMB under the PRA. The collections
of information in the following FDA regulations have been approved by
OMB as listed in the following table:

------------------------------------------------------------------------
                                                            OMB control
          21 CFR part                     Topic                 No.
------------------------------------------------------------------------
807, subpart E.................  Premarket notification.       0910-0120
800, 801, and 809..............  Medical Device Labeling       0910-0485
                                  Regulations.
803............................  Medical Devices;              0910-0437
                                  Medical Device
                                  Reporting;
                                  Manufacturer
                                  reporting, importer
                                  reporting, user
                                  facility reporting,
                                  distributor reporting.
------------------------------------------------------------------------

    Dated: December 22, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2020-28816 Filed 12-29-20; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 87, Number 163 (Wednesday, August 24, 2022)]
[Notices]
[Pages 52089-52092]
[FR Doc No: 2022-18189]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-95552; File No. SR-CboeEDGA-2022-011]

Self-Regulatory Organizations; Cboe EDGA Exchange, Inc.; Notice
of Filing and Immediate Effectiveness of a Proposed Rule Change To
Introduce a New Data Product To Be Known as the Short Volume Report

August 18, 2022.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that on August 9, 2022, Cboe EDGA Exchange, Inc. (``Exchange'' or
``EDGA'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II below, which Items have been prepared by the Exchange. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    Cboe EDGA Exchange, Inc. (the ``Exchange'' or ``EDGA'') is filing
with the Securities and Exchange Commission (``Commission'') a proposed
rule change to Exchange Rule 13.8 to introduce a new data product to be
known as the Short Volume Report. The text of the proposed rule change
is provided in Exhibit 5.
    The text of the proposed rule change is also available on the
Exchange's website (http://markets.cboe.com/us/equities/regulation/rule_filings/edga/), at the Exchange's Office of the Secretary, and at
the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange seeks to amend Rule 13.8 to adopt paragraph 13.8(h),
which introduces a new data product, the Short Volume Report. A
description of each market data product offered by the Exchange is
provided in Exchange Rule 13.8 and proposed Rule 13.8(h) provides that
the Short Volume Report is an end-of-day report that summarizes certain
equity trading activity on the Exchange, and includes trade date,\3\
total volume,\4\ sell short volume,\5\ and sell short exempt volume,\6\
by symbol.\7\ The Short Volume Report will be available for purchase to
both EDGA Members (``Members'') \8\ as well as non-Members.\9\
---------------------------------------------------------------------------

    \3\ ``Trade date'' is the date of the trading activity.
    \4\ ``Total volume'' is the total share volume of all order
executions.
    \5\ ``Sell Short volume'' is the total share volume of all short
order executions, (Sell Short + Sell Short Exempt).
    \6\ ``Short exempt volume'' is the total share volume of all
short exempt order executions.
    \7\ Symbol refers to the Cboe formatted symbol in which the
trading activity occurred. See https://cdn.cboe.com/resources/membership/US_Symbology_Reference.pdf.
    \8\ The term ``Member'' shall mean any registered broker or
dealer that has been admitted to membership in the Exchange. A
Member will have the status of a ``member'' of the Exchange as that
term is defined in Section 3(a)(3) of the Act. Membership may be
granted to a sole proprietor, partnership, corporation, limited
liability company or other organization which is a registered broker
or dealer pursuant to Section 15 of the Act, and which has been
approved by the Exchange. See Exchange Rule 1.5(n), definition of
``Member''.
    \9\ The Exchange intends to submit a separate filing to
establish fees for the Short Volume Report.
---------------------------------------------------------------------------

    The Exchange notes that the data fields included in the Short
Volume Report are essentially identical to the fields included by the
New York Stock Exchange LLC (``NYSE'') in their Daily Short Volume
file.\10\ Specifically, the NYSE Daily Short Volume file also includes
trade date,\11\ symbol,\12\ short exempt volume,\13\ short volume,\14\
and total volume.\15\ The proposed Short Volume Report is also similar
to Nasdaq's Daily Short Sale Volume file \16\ which includes, date,\17\
symbol,\18\ short volume,\19\ total volume,\20\ and market center.\21\
The Short Volume Report will be available for purchase \22\ by both
Members and non-Members on a monthly subscription basis, and
subscribers will receive a daily end-of-day file. Additionally, like
NYSE, the Exchange will offer historical daily Short Volume Reports.
Historical daily Short Volume Reports will be available for purchase
dating back to January 2, 2015,\23\ and will include the same data
fields as the daily end-of-day files.\24\
---------------------------------------------------------------------------

    \10\ See NYSE Daily Short Volume Client Specification, available
at: https://www.nyse.com/publicdocs/nyse/data/Daily_Short_Volume_Client_Spec_v1.3.pdf. The NYSE Daily Short Volume
includes trade date, symbol, short exempt volume, short volume, and
total volume. Unlike NYSE, the proposed Short Volume Report will not
include the trading exchange, as the proposed report includes short
sale volume only for transactions executed on EDGA. Additionally,
NYSE's Daily Short Volume file specifies that short volume is
comprised of the sum of, (sell short volume + sell short exempt
volume + sell short with slide). While the Exchange does not
specifically flag sell short with slide transactions, such
transactions are recognized simply as sell short or sell short
exempt and are thus included in the Exchange's sell short and sell
short exempt volume totals.
    \11\ NYSE ``Trade date'' is the date of trading session
activity.
    \12\ NYSE ``Symbol'' is defined in the NYSE Symbology
Specification, available at: https://www.nyse.com/publicdocs/nyse/data/Daily_Short_Volume_Client_Spec_v1.3.pdf.
    \13\ NYSE ``Short Exempt Volume'' is the total share volume of
all Short Exempt order executions.
    \14\ NYSE ``Short Volume'' is the total share volume of all
short order executions, (Sell Short + Sell Short Exempt + Sell Short
with Slide).
    \15\ NYSE ``Total Volume'' is the total share volume of all
order executions.
    \16\ See Specifications for Daily Short Sale Volume file,
available at: https://www.nasdaqtrader.com/content/technicalsupport/specifications/dataproducts/ShortSaleFileSpecifications.pdf. The
Exchange notes that Nasdaq's comparable product, the Daily Short
Sale Volume file, reflects aggregate information across their
affiliated equity exchanges. The Exchange is not proposing an
aggregated Short Volume Report across its affiliated equity
exchanges, and the proposal includes only volume on EDGA. As such,
the volumes calculated on Nasdaq reports will differ from that in
the proposed Short Volume Report.
    \17\ Nasdaq ``Date'' is the trade date (YYYMMDD).
    \18\ Nasdaq ``Symbol'' is the Trading Symbol.
    \19\ Nasdaq ``Short Volume'' is the aggregate reported share
volume of executed short sales during regular trading hours.
    \20\ Nasdaq ``Total Volume'' is the aggregate reported share
volume of all executed trades during regular trading hours.
    \21\ Nasdaq ``Market Center'' is the market identifier (Q =
NASDAQ for NASDAQ file, B = Boston for Boston file, X = PSX).
    \22\ The Exchange notes that short sale information that is
available free of charge on the Cboe website will continue to be
publicly available upon approval of this proposal.
    \23\ Historical Short Volume Reports will be available for
purchase on an ad hoc basis.
    \24\ The Exchange notes that NYSE also offers historical daily
short sale files. See https://www.nyse.com/market-data/historical/taq-nyse-group-short-sales.
---------------------------------------------------------------------------

    The Exchange anticipates that a wide variety of market participants
will purchase the proposed Short Volume Report, including, but not
limited to, active equity trading firms and academic institutions. For
example, the Exchange notes that academic institutions may utilize the
Short Volume Report data and as a result promote research and studies
of the equities industry to the benefit of all market participants. The
Exchange further believes the proposed Short Volume Report may provide
helpful trading information regarding investor sentiment that may allow
market participants to make more informed trading decisions and may be
used to create and test trading models and analytical strategies and
provide comprehensive insight into trading on the Exchange. The
proposal is a completely voluntary product, in that the Exchange is not
required by any rule or regulation to make this data available and that
potential subscribers may purchase it only if they voluntarily choose
to do so.
2. Statutory Basis
    The Exchange believes the proposed rule change is consistent with
the Securities Exchange Act of 1934 (the ``Act'') and the rules and
regulations thereunder applicable to the Exchange and, in particular,
the requirements of Section 6(b) of the Act.\25\ Specifically, the
Exchange believes the proposed rule change is consistent with the
Section 6(b)(5) \26\ requirements that the rules of an exchange be
designed to prevent fraudulent and manipulative acts and practices, to
promote just and equitable principles of trade, to foster cooperation
and coordination with persons engaged in regulating, clearing,
settling, processing information with respect to, and facilitating
transactions in securities, to remove impediments to and perfect the
mechanism of a free and open market and a national market system, and,
in general, to protect investors and the public interest. Additionally,
the Exchange believes the proposed rule change is consistent with the
Section 6(b)(5) \27\ requirement that the rules of an exchange not be
designed to permit unfair discrimination between customers, issuers,
brokers, or dealers.
---------------------------------------------------------------------------

    \25\ 15 U.S.C. 78f(b).
    \26\ 15 U.S.C. 78f(b)(5).
    \27\ Id.
---------------------------------------------------------------------------

    In adopting Regulation NMS, the Commission granted self-regulatory
organizations (``SROs'') and broker-dealers increased authority and
flexibility to offer new and unique market data to the public. It was
believed that this authority would expand the amount of data available
to consumers, and also spur innovation and competition for the
provision of market data. The Exchange believes that the proposed Short
Volume Report would further broaden the availability of U.S. equity
market data to investors consistent with the principles of Regulation
NMS. The proposal also promotes increased transparency through the
dissemination of short volume data. The proposed rule change would
benefit investors by providing

access to the Short Volume Report data, which may promote better
informed trading, as well as research and studies of the equities
industry.
    Moreover, as noted above, NYSE offers a Daily Short Volume file
which provides data that is essentially identical to that currently
proposed by the Exchange--trade date, symbol, short volume, short
exempt volume, and total volume.\28\ The proposed Short Volume Report
is also similar to Nasdaq's Daily Short Sale Volume file which
includes, date, symbol, short volume, total volume, and market
center.\29\ Accordingly, the proposed Short Volume Report does not
provide a unique or novel data offering, but rather offers data points
consistent with other data products already available and utilized by
market participants today.
---------------------------------------------------------------------------

    \28\ Supra note 10.
    \29\ Supra note 16.
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. Rather, the Exchange
believes that the proposal will promote fair competition among the
national securities exchanges by permitting the Exchange to offer a
data product that provides substantially the same data offered by other
competitor equities exchanges. Additionally, the Short Volume Report
will be available equally to Members and non-Members. Market
participants are not required to purchase the Short Volume Report, and
the Exchange is not required to make the Short Volume Report available
to investors. Rather, the Exchange is voluntarily making the Short
Volume Report available, as requested by customers, and market
participants may choose to receive (and pay for) this data based on
their own business needs. Potential purchasers may request the data at
any time if they believe it to be valuable or may decline to purchase
such data. Given the above, the Exchange does not believe the proposed
rule change will result in any burden on competition that is not
necessary or appropriate in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The Exchange neither solicited nor received comments on the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the foregoing proposed rule change does not: (i)
significantly affect the protection of investors or the public
interest; (ii) impose any significant burden on competition; and (iii)
become operative for 30 days from the date on which it was filed, or
such shorter time as the Commission may designate, it has become
effective pursuant to Section 19(b)(3)(A) of the Act \30\ and Rule 19b-
4(f)(6) thereunder.\31\
---------------------------------------------------------------------------

    \30\ 15 U.S.C. 78s(b)(3)(A).
    \31\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)(iii)
requires a self-regulatory organization to give the Commission
written notice of its intent to file the proposed rule change, along
with a brief description and text of the proposed rule change, at
least five business days prior to the date of filing of the proposed
rule change, or such shorter time as designated by the Commission.
The Exchange has satisfied this requirement.
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) \32\ normally
does not become operative prior to 30 days after the date of the
filing. However, pursuant to Rule 19b-4(f)(6)(iii),\33\ the Commission
may designate a shorter time if such action is consistent with the
protection of investors and the public interest. The Exchange has
requested that the Commission waive the 30-day operative delay so that
the proposal may become operative prior to 30 days after the date of
the filing. The Exchange states that waiver of the operative delay is
consistent with the protection of investors and the public interest
because the proposed Short Volume Report is nearly identical to the
currently available NYSE Daily Short Volume file and Nasdaq Daily Short
Volume file and would permit the Exchange to immediately make the Short
Volume Report available to subscribers as an alternative to similar
products offered by NYSE and Nasdaq. The Commission believes that
waiver of the 30-day operative delay is consistent with the protection
of investors and the public interest because the proposed rule change
does not raise any new or novel issues. Accordingly, the Commission
hereby waives the operative delay and designates the proposed rule
change operative upon filing.\34\
---------------------------------------------------------------------------

    \32\ 17 CFR 240.19b-4(f)(6).
    \33\ 17 CFR 240.19b-4(f)(6)(iii).
    \34\ For purposes only of waiving the 30-day operative delay,
the Commission also has considered the proposed rule's impact on
efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings to
determine whether the proposed rule change should be approved or
disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to [email protected]. Please include
File Number SR-CboeEDGA-2022-011 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.

All submissions should refer to File Number SR-CboeEDGA-2022-011. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's internet website (http://www.sec.gov/rules/sro.shtml).
Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for website viewing and printing in
the Commission's Public Reference Room, 100 F Street NE, Washington, DC
20549 on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of the Exchange. All comments
received will be posted without change. Persons submitting comments are
cautioned that we do not redact or edit personal identifying
information from comment submissions. You should

submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-CboeEDGA-2022-011 and should
be submitted on or before September 14, 2022.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\35\
---------------------------------------------------------------------------

    \35\ 17 CFR 200.30-3(a)(12), (59).
---------------------------------------------------------------------------

Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2022-18189 Filed 8-23-22; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 83, Number 34 (Tuesday, February 20, 2018)]
[Proposed Rules]
[Pages 7117-7120]
[FR Doc No: 2018-03212]

========================================================================
Proposed Rules
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.

========================================================================

Federal Register / Vol. 83, No. 34 / Tuesday, February 20, 2018 /
Proposed Rules

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2018-0111; Product Identifier 2017-NM-059-AD]
RIN 2120-AA64

Airworthiness Directives; Airbus Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: We propose to supersede Airworthiness Directive (AD) 2017-07-
07, for certain Airbus Model A330-200, A330-300, A340-200, and A340-300
series airplanes. AD 2017-07-07 requires repetitive inspections of
certain fastener holes, and related investigative and corrective
actions if necessary. Since we issued AD 2017-07-07, we have determined
that certain other airplanes could also be affected by the unsafe
condition specified in AD 2017-07-07. This proposed AD would retain the
requirements of AD 2017-07-07 and expand the applicability. We are
proposing this AD to address the unsafe condition on these products.

DATES: We must receive comments on this proposed AD by April 6, 2018.

ADDRESSES: You may send comments, using the procedures found in 14 CFR
11.43 and 11.45, by any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE, Washington, DC 20590.
     Hand Delivery: Deliver to Mail address above between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
    For service information identified in this NPRM, contact Airbus
SAS, Airworthiness Office--EAL, 1 Rond Point Maurice Bellonte, 31707
Blagnac Cedex, France; telephone: +33 5 61 93 36 96; fax: +33 5 61 93
45 80; email: [email protected]; internet: http://www.airbus.com. You may view this referenced service information at the
FAA, Transport Standards Branch, 1601 Lind Avenue SW, Renton, WA. For
information on the availability of this material at the FAA, call 425-
227-1221.

Examining the AD Docket

    You may examine the AD docket on the internet at http://www.regulations.gov by searching for and locating Docket No. FAA-2018-
0111; or in person at the Docket Management Facility between 9 a.m. and
5 p.m., Monday through Friday, except Federal holidays. The AD docket
contains this proposed AD, the regulatory evaluation, any comments
received, and other information. The street address for the Docket
Operations office (telephone:<PHONE_NUMBER>) is in the ADDRESSES
section. Comments will be available in the AD docket shortly after
receipt.

FOR FURTHER INFORMATION CONTACT: Vladimir Ulyanov, Aerospace Engineer,
International Section, Transport Standards Branch, FAA, 1601 Lind
Avenue SW, Renton, WA 98057-3356; telephone:<PHONE_NUMBER>; fax: 425-
227-1149.

SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposal. Send your comments to an address listed
under the ADDRESSES section. Include ``Docket No. FAA-2018-0111;
Product Identifier 2017-NM-059-AD'' at the beginning of your comments.
We specifically invite comments on the overall regulatory, economic,
environmental, and energy aspects of this proposed AD. We will consider
all comments received by the closing date and may amend this proposed
AD based on those comments.
    We will post all comments we receive, without change, to http://www.regulations.gov, including any personal information you provide. We
will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    We issued AD 2017-07-07, Amendment 39-18845 (82 FR 18547, April 20,
2017) (``AD 2017-07-07''), for certain Airbus Model A330-200, A330-300,
A340-200, and A340-300 series airplanes with manufacturer serial
numbers (MSN) 0176 through 0915 inclusive. These airplanes have Airbus
modification 44360 embodied in production. AD 2017-07-07 was prompted
by a report of cracking at fastener holes located at frame (FR) 40 on
the lower shell panel junction. AD 2017-07-07 requires repetitive
inspections of certain fastener holes, and related investigative and
corrective actions if necessary. Airbus then introduced the
modification 55792 to reinforce the fuselage at FR40. We issued AD
2017-07-07 to detect and correct cracking at FR40 on the lower shell
panel junction; such cracking could lead to reduced structural
integrity of the fuselage.
    Since we issued AD 2017-07-07, we have determined that airplanes in
the post-modification 55792 configuration could be also affected by
crack initiation and propagation at fastener holes located at FR40 on
the lower shell panel junction.
    The European Aviation Safety Agency (EASA), which is the Technical
Agent for the Member States of the European Union, has issued EASA AD
2017-0063, dated April 12, 2017 (referred to after this as the
Mandatory Continuing Airworthiness Information, or ``the MCAI''), to
correct an unsafe condition for certain Airbus Model A330-200, A330-
300, and A340-200 series airplanes, and Model A340-312 and -313
airplanes. The MCAI states:

    During full scale fatigue test of the Frame (FR) 40 to fuselage
skin panel junction, fatigue damage was found. Corrective actions
consisted of in-service installation of an internal reinforcing
strap on the related junction, as currently required by DGAC
[Direction G[eacute]n[eacute]rale de l'Aviation Civile] France AD
1999-448-126(B), which refers to Airbus Service Bulletin (SB) A340-
53-4104 Revision 02, and [DGAC] AD 2001-070(B), which refers to
Airbus SB A330-53-3093 Revision 04; retrofit improvement of internal
reinforcing strap fatigue life through recommended Airbus SB A330-
53-3145; and introducing a design improvement in production through
Airbus mod 44360.

    After those actions were implemented, cracks were found on both
left-hand (LH) and right-hand (RH) sides on internal strap, butt
strap, keel beam fitting, or forward fitting FR40 flange. These
findings were made during embodiment of a FR40 web repair on an A330
aeroplane, and during keel beam replacement on an A340 aeroplane,
where the internal strap was removed and a special detailed
inspection (SDI) was performed on several holes.
    This condition, if not detected and corrected, could affect the
structural integrity of the centre fuselage of the aeroplane.
    Prompted by these findings, Airbus issued SB A330-53-3215 and SB
A340-53-4215, providing inspection instructions. Consequently, EASA
issued AD 2014-0136 [which corresponds to FAA AD 2017-07-07] to
require repetitive SDI (rototest) of 10 fastener holes located at
the FR40 lower shell panel junction on both LH and RH sides and,
depending on findings, accomplishment of applicable corrective
action(s).
    Since that [EASA] AD was issued, prompted by the results of
complementary fatigue analyses, it was determined that post-mod
55792 aeroplanes could be also affected by crack initiation and
propagation at this area of the fuselage. These analyses
demonstrated that post-mod 55792 aeroplanes must follow the same
maintenance program as aeroplanes in post-mod 55306 and pre-mod
55792 configuration. Consequently, Airbus published SB A330-53-3215
Revision 02 and SB A340-53-4215 Revision 02 to expand the
Effectivity accordingly.
    For the reasons described above, this [EASA] AD retains the
requirements of EASA AD 2014-0136, which is superseded, which now
also apply to aeroplanes in post-mod 55792 configuration [the
applicability identifies airplanes in post-mod 44360 configuration].

    AD 2017-07-07 includes Model A340-311 airplanes in its
applicability. Airbus Model A340-311 airplanes are not identified in
the applicability of this proposed AD because those airplanes are not
affected by the identified unsafe condition. All of those airplanes are
in the pre-Airbus modification 44360 configuration. The MCAI does not
include Model A340-311 airplanes in its applicability.
    The compliance time ranges between 20,000 flight cycles or 65,400
flight hours and 20,800 flight cycles or 68,300 flight hours, depending
on airplane utilization and configuration. The repetitive inspection
interval ranges between 14,000 flight cycles or 95,200 flight hours and
24,600 flight cycles or 98,700 flight hours, depending on airplane
utilization and configuration. You may examine the MCAI in the AD
docket on the internet at http://www.regulations.gov by searching for
and locating Docket No. FAA-2018-0111.

Related Service Information Under 1 CFR Part 51

    Airbus has issued Airbus Service Bulletin A330-53-3215, Revision
02, dated November 23, 2016 (``A330-53-3215, R2''); and Airbus Service
Bulletin A340-53-4215, Revision 02, dated November 23, 2016. This
service information describes procedures for repetitive rototest
inspections of certain fastener holes, and related investigative and
corrective actions if necessary. These documents are distinct since
they apply to different airplane models. This service information is
reasonably available because the interested parties have access to it
through their normal course of business or by the means identified in
the ADDRESSES section.

FAA's Determination and Requirements of This Proposed AD

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to our bilateral agreement with the State of Design Authority, we have
been notified of the unsafe condition described in the MCAI and service
information referenced above. We are proposing this AD because we
evaluated all pertinent information and determined an unsafe condition
exists and is likely to exist or develop on other products of these
same type designs.

Differences Between This Proposed AD and the MCAI or Service
Information

    The MCAI includes Model A340-211 airplanes in its applicability.
Airbus Model A340-211 airplanes are not identified in the applicability
of this proposed AD because those airplanes are not affected by the
identified unsafe condition. All of those airplanes are in the pre-
Airbus modification 44360 configuration. We have coordinated this
difference with EASA.
    Paragraph 1.E. ``Compliance,'' of A330-53-3215, R2, specifies
weight variant (WV) 050 in the condition column of table 1,
configuration 003. We have determined that for the purposes of this AD,
WV060 and WV080 are also affected.

Costs of Compliance

    We estimate that this proposed AD affects 99 airplanes of U.S.
registry.
    We estimate the following costs to comply with this proposed AD:

                                                 Estimated Costs
----------------------------------------------------------------------------------------------------------------
                                                                                Cost on U.S.
           Action                  Labor cost         Parts cost       Cost per product          operators
----------------------------------------------------------------------------------------------------------------
Inspection.................  42 work-hours x $85                $0  $3,570 per inspection  $353,430 per
                              per hour = $3,570                      cycle.                 inspection cycle.
                              per inspection cycle.
----------------------------------------------------------------------------------------------------------------

    We estimate the following costs to do any necessary repairs that
are required based on the results of the required inspection. We have
no way of determining the number of aircraft that might need these
repairs:

                                               On-Condition Costs
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per
                    Action                                 Labor cost               Parts cost        product
----------------------------------------------------------------------------------------------------------------
Repair........................................  46 work-hours x $85 per hour =            $2,358          $6,268
                                                 $3,910.
----------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. ``Subtitle VII: Aviation
Programs,'' describes in more detail the scope of the Agency's
authority.
    We are issuing this rulemaking under the authority described in
``Subtitle VII, Part A, Subpart III, Section 44701: General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures

the Administrator finds necessary for safety in air commerce. This
regulation is within the scope of that authority because it addresses
an unsafe condition that is likely to exist or develop on products
identified in this rulemaking action.
    This AD is issued in accordance with authority delegated by the
Executive Director, Aircraft Certification Service, as authorized by
FAA Order 8000.51C. In accordance with that order, issuance of ADs is
normally a function of the Compliance and Airworthiness Division, but
during this transition period, the Executive Director has delegated the
authority to issue ADs applicable to transport category airplanes to
the Director of the System Oversight Division.

Regulatory Findings

    We determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979);
    3. Will not affect intrastate aviation in Alaska; and
    4. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by removing Airworthiness Directive (AD)
2017-07-07, Amendment 39-18845 (82 FR 18547, April 20, 2017), and
adding the following new AD:

Airbus: Docket No. FAA-2018-0111; Product Identifier 2017-NM-059-AD.

(a) Comments Due Date

    We must receive comments by April 6, 2018.

(b) Affected ADs

    This AD replaces AD 2017-07-07, Amendment 39-18845 (82 FR 18547,
April 20, 2017) (``AD 2017-07-07'').

(c) Applicability

    This AD applies to the airplanes, certificated in any category,
identified in paragraphs (c)(1) and (c)(2) of this AD, all
manufacturer serial numbers on which Airbus Modification 44360 has
been embodied in production.
    (1) Airbus Model A330-201, -202, -203, -223, -243, -301, -302, -
303, -321, -322, -323, -341, -342, and -343 airplanes.
    (2) Airbus Model A340-212, -213, -312, and -313 airplanes.

(d) Subject

    Air Transport Association (ATA) of America Code 53, Fuselage.

(e) Reason

    This AD was prompted by a report of cracking at fastener holes
located at frame (FR) 40 on the lower shell panel junction. We are
issuing this AD to detect and correct cracking at FR40 on the lower
shell panel junction; such cracking could lead to reduced structural
integrity of the fuselage.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Compliance Times for the Actions Required by Paragraph (h) of This
AD

    Accomplish the actions required by paragraph (h) of this AD at
the times specified in paragraphs (g)(1) and (g)(2) of this AD, as
applicable.
    (1) For airplanes having serial numbers 0176 through 0915
inclusive: Within the compliance times defined in table 1 to
paragraph (g)(1) of this AD, and, thereafter, at intervals not to
exceed the compliance times defined in Airbus Service Bulletin A330-
53-3215, Revision 02, dated November 23, 2016 (``A330-53-3215,
R2''); or Airbus Service Bulletin A340-53-4215, Revision 02, dated
November 23, 2016 (``A340-53-4215, R2''); as applicable, depending
on airplane utilization and configuration. As of the effective date
of this AD, where paragraph 1.E. ``Compliance,'' of A330-53-3215, R2
specifies weight variant (WV) 050 in the condition column of table
1, configuration 003, for the purposes of this AD, WV060 and WV080
are also included.
[GRAPHIC] [TIFF OMITTED] TP20FE18.000

    (2) For all airplanes except those identified in paragraph
(g)(1) of this AD: Before exceeding the applicable compliance time
``threshold'' defined in paragraph 1.E., ``Compliance,'' of A330-53-
3215, R2; or A340-53-4215, R2; as applicable, depending on airplane
utilization and configuration and to be counted from airplane first
flight, and, thereafter, at intervals not to exceed the compliance
times specified in paragraph 1.E., ``Compliance'' of A330-53-3215,
R2; or A340-53-4215, R2; as applicable, depending on airplane
utilization and configuration. Where paragraph 1.E. ``Compliance,''
of A330-53-3215, R2 specifies weight variant WV050 in the condition
column of table 1, configuration 003, for the purposes of this AD,
WV060 and WV080 are also included.

(h) Repetitive Inspections and Related Investigative and Corrective
Actions

    At the applicable compliance times specified in paragraph (g) of
this AD: Accomplish a special detailed inspection of the 10 fastener
holes located at FR40 lower shell panel junction on both left-hand
and right-hand sides, in accordance with the Accomplishment
Instructions of A330-53-3215, R2; or A340-53-4215, R2; as
applicable.
    (1) If, during any inspection required by the introductory text
of paragraph (h) of this AD, any crack is detected, before further
flight, accomplish all applicable related investigative and
corrective actions, in accordance with the Accomplishment
Instructions of A330-53-3215, R2; or A340-53-4215, R2; as
applicable, except where A330-53-3215, R2; or A340-53-4215, R2;
specifies to contact Airbus for repair instructions, and specifies
that action as ``RC,'' this AD requires repair before further flight
using a method approved by the Manager, International Section,
Transport Standards Branch, FAA; or European Aviation Safety Agency
(EASA); or Airbus's EASA Design Organization Approval (DOA). If
approved by the DOA, the approval must include the DOA-authorized
signature.
    (2) If, during any inspection required by the introductory text
of paragraph (h) of this AD, the diameter of a fastener hole is
found to be outside the tolerances of the transition fit as
specified in A330-53-3215, R2; or A340-53-4215, R2; as applicable;
and A330-53-3215, R2; or A340-53-4215, R2; specifies to contact
Airbus for repair instructions, and specifies that action as ``RC,''
before further flight, repair using a method approved by the
Manager, International Section, Transport Standards Branch, FAA; or
EASA; or Airbus's EASA DOA. If approved by the DOA, the approval
must include the DOA-authorized signature.
    (3) Accomplishment of corrective actions, as required by
paragraph (h)(1) of this AD, does not constitute terminating action
for the repetitive inspections required by the introductory text of
paragraph (h) of this AD.
    (4) Accomplishment of a repair on an airplane, as required by
paragraph (h)(2) of this AD, does not constitute terminating action
for the repetitive inspections required by the introductory text of
paragraph (h) of this AD for that airplane, unless the method
approved by the Manager, International Section, Transport Standards
Branch, FAA; or EASA; or Airbus's EASA DOA indicates otherwise.

(i) No Reporting Requirement

    Although A330-53-3215, R2 and A340-53-4215, R2, specify to
submit certain information to the manufacturer, and specify that
action as ``RC,'' this AD does not include that requirement.

(j) Credit for Previous Actions

    This paragraph provides credit for the inspections required by
the introductory text of (h) of this AD and the related
investigative and corrective actions required by paragraph (h)(1) of
this AD, if those actions were performed before May 25, 2017 (the
effective date of AD 2017-07-07), using Airbus Service Bulletin
A330-53-3215, dated June 21, 2013; or Revision 01, dated April 17,
2014; or Airbus Service Bulletin A340-53-4215, dated June 21, 2013;
or Revision 01, dated April 17, 2014; as applicable.

(k) Other FAA AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Section, Transport Standards Branch, FAA, has the
authority to approve AMOCs for this AD, if requested using the
procedures found in 14 CFR 39.19. In accordance with 14 CFR 39.19,
send your request to your principal inspector or local Flight
Standards District Office, as appropriate. If sending information
directly to the International Section, send it to the attention of
the person identified in paragraph (l)(2) of this AD. Information
may be emailed to: [email protected]. Before using any
approved AMOC, notify your appropriate principal inspector, or
lacking a principal inspector, the manager of the local flight
standards district office/certificate holding district office.
    (2) Contacting the Manufacturer: As of the effective date of
this AD, for any requirement in this AD to obtain corrective actions
from a manufacturer, the action must be accomplished using a method
approved by the Manager, International Section, Transport Standards
Branch, FAA; or EASA; or Airbus's EASA DOA. If approved by the DOA,
the approval must include the DOA-authorized signature.
    (3) Required for Compliance (RC): Except as required by
paragraphs (g)(1), (g)(2), (h)(1), (h)(2), and (i) of this AD: If
any service information contains procedures or tests that are
identified as RC, those procedures and tests must be done to comply
with this AD; any procedures or tests that are not identified as RC
are recommended. Those procedures and tests that are not identified
as RC may be deviated from using accepted methods in accordance with
the operator's maintenance or inspection program without obtaining
approval of an AMOC, provided the procedures and tests identified as
RC can be done and the airplane can be put back in an airworthy
condition. Any substitutions or changes to procedures or tests
identified as RC require approval of an AMOC.

(l) Related Information

    (1) Refer to Mandatory Continuing Airworthiness Information
(MCAI) EASA AD 2017-0063, dated April 12, 2017, for related
information. This MCAI may be found in the AD docket on the internet
at http://www.regulations.gov by searching for and locating Docket
No. FAA-2018-0111.
    (2) For more information about this AD, contact Vladimir
Ulyanov, Aerospace Engineer, International Section, Transport
Standards Branch, FAA, 1601 Lind Avenue SW, Renton, WA 98057-3356;
telephone:<PHONE_NUMBER>; fax:<PHONE_NUMBER>.
    (3) For service information identified in this AD, contact
Airbus SAS, Airworthiness Office--EAL, 1 Rond Point Maurice
Bellonte, 31707 Blagnac Cedex, France; telephone: +33 5 61 93 36 96;
fax: +33 5 61 93 45 80; email: [email protected];
internet: http://www.airbus.com. You may view this service
information at the FAA, Transport Standards Branch, 1601 Lind Avenue
SW, Renton, WA. For information on the availability of this material
at the FAA, call<PHONE_NUMBER>.

    Issued in Renton, Washington, on February 9, 2018.
Michael Kaszycki,
Acting Director, System Oversight Division, Aircraft Certification
Service.
[FR Doc. 2018-03212 Filed 2-16-18; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 81, Number 119 (Tuesday, June 21, 2016)]
[Notices]
[Pages 40393-40394]
[FR Doc No: 2016-14743]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2015-0436]

Agency Information Collection Activities; Extension of a
Currently Approved Information Collection Request: Financial
Responsibility for Motor Carriers of Passengers and Motor Carriers of
Property

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FMCSA
announces its plan to submit the Information Collection Request (ICR)
described below to the Office of Management and Budget (OMB) for review
and approval. The FMCSA and the public use the information (which is
currently being collected) to verify that a motor carrier of property
or passengers has obtained, and has in effect, the required minimum
levels of financial responsibility. Statute mandates that motor
carriers maintain proof of the required financial responsibility at
their principal places of business, available upon request of an FMCSA
safety investigator during compliance reviews. Insurance Endorsements
and Surety Bonds are considered public information and must be produced
by a motor carrier of passengers for review upon reasonable request by
a member of the public.

DATES: Please send your comments on or before July 21, 2016. OMB must
receive your comments by this date in order to act quickly on the ICR.

ADDRESSES: All comments should reference Federal Docket Management
System (FDMS) Docket Number FMCSA-2015-0436. Interested persons are
invited to submit written comments on the proposed information
collection to the Office of Information and Regulatory Affairs, Office
of Management and Budget. Comments should be addressed to the attention
of the Desk Officer, Department of Transportation/Federal Motor Carrier
Safety Administration, and sent via electronic mail to
<EMAIL_ADDRESS>or faxed to<PHONE_NUMBER>, or mailed to
the Office of Information and Regulatory Affairs, Office of Management
and Budget, Docket Library, Room 10102, 725 17th Street NW.,
Washington, DC 20503.

FOR FURTHER INFORMATION CONTACT: Ms. Tura Gatling, Registration,
Licensing, and Insurance Division, Office of Registration and Safety
Information, Department of Transportation, Federal Motor Carrier Safety
Administration, West Building 6th Floor, 1200 New Jersey Avenue SE.,
Washington, DC 20590. Telephone:<PHONE_NUMBER>; email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:
    Title: Financial Responsibility for Motor Carriers of Passengers
and Motor Carriers of Property.
    OMB Control Number: 2126-0008.
    Type of Request: Extension of a currently-approved information
collection.
    Respondents: Insurance and surety companies of motor carriers of
property (Forms MCS-90 and MCS-82) and motor carriers of passengers
(Forms MCS-90B and MCS-82B).
    Estimated Number of Respondents: 8,004 [896 insurers for IC1 + 896
insurers for IC2 + 231 insurers for IC3 + 231 insurers for IC4 + 5,750
carriers for IC5 (Canada: 111 passenger carriers + 2,716 property
carriers) + (Mexico & NNA: 2 passenger carriers + 2,921 property
carriers)].
    Estimated Time per Response: The FMCSA estimates it takes two
minutes to complete the Endorsement for Motor Carrier Policies of
Insurances for Public Liability or the Motor Carrier Public Liability
Surety Bond; and one minute to place either document on board the
vehicle [49 CFR 387.7(f)(property); 387.31(f)(passengers)]. These
endorsements and surety bonds are maintained at the motor carrier's
principal place of business [49 CFR 387.7(d); 49 CFR 387.31(d)].
    Expiration Date: June 30, 2016.
    Frequency of Response: Upon creation, change or replacement of an
insurance policy or surety bond.
    Estimated Total Annual Burden: 4,777 hours [4,065 annual burden
hours for ICs 1-4 + 712 annual burden hours for IC-5 document
replacement = 4,777].
    Background: The Secretary of Transportation is responsible for
implementing regulations which establish minimal levels of financial
responsibility for: (1) For-hire motor carriers of property to cover
public liability, property damage and environmental restoration, and
(2) for-hire motor carriers of passengers to cover public liability and
property damage. The Endorsement for Motor Carrier Policies of
Insurance for Public Liability (Forms MCS-90/90B) and the Motor Carrier
Public Liability Surety Bond (Forms MCS-82/82B) contain the minimum
amount of information necessary to document that a motor

carrier of property or passengers has obtained, and has in effect, the
minimum levels of financial responsibility as set forth in applicable
regulations (motor carriers of property--49 CFR 387.9; and motor
carriers of passengers--49 CFR 387.33). FMCSA and the public can verify
that a motor carrier of property or passengers has obtained, and has in
effect, the required minimum levels of financial responsibility, by use
of the information enclosed within these documents.
    On February 25, 2016, FMCSA published a notice in the Federal
Register requesting public comments on the ``Financial Responsibility
for Motor Carriers of Passengers and Motor Carriers of Property''
Information Collection Request, OMB Control Number 2126-0008 (81 FR
9582). Two comments were received in response to this notice. FMCSA
contacted one of the commenters and determined that the question was
about a company-specific FMCSA registration issue unrelated to the
notice, which has already been resolved. FMCSA believes the other
comment can be interpreted as an advertisement for the commenter's
company, and not a question about the notice.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including: (1) whether the proposed
collection is necessary for the performance of FMCSA's functions; (2)
the accuracy of the estimated burden; (3) ways for the FMCSA to enhance
the quality, usefulness, and clarity of the collected information; and
(4) ways that the burden could be minimized without reducing the
quality of the collected information.

    Issued under the authority delegated in 49 CFR 1.87 on: June 15,
2016.
G. Kelly Regal,
Associate Administrator for Office of Research and Information
Technology.
[FR Doc. 2016-14743 Filed 6-20-16; 8:45 am]
 BILLING CODE 4910-EX-P


[Federal Register Volume 78, Number 162 (Wednesday, August 21, 2013)]
[Notices]
[Page 51718]
[FR Doc No: 2013-20404]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP10-149-000.
    Applicants: Great Lakes Gas Transmission Limited Par.
    Description: Petition to Amend Settlement and Motion for Shortened
Answer Period and Expedited Action.
    Filed Date: 8/13/13.
    Accession Number: 20130813-5099.
    Comments Due: 5 p.m. ET 8/20/13.

    Docket Numbers: RP13-1245-000.
    Applicants: Gulf South Pipeline Company, LP.
    Description: New No Notice Service (NNS-A)--In compliance with App
to Aband Capacity by Lease to be effective 2/1/2014.
    Filed Date: 8/13/13.
    Accession Number: 20130813-5036.
    Comments Due: 5 p.m. ET 8/26/13.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: August 14, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2013-20404 Filed 8-20-13; 8:45 am]
BILLING CODE 6717-01-P